Overexpression of HLA class I molecules on T cells among type 1 diabetes Brazilian patients

Molecular Immunology

Volumn 41, Issue 10, 2004, Pages 1047-1050

  Fernandes, Ana Paula M ^a   Foss, Milton C ^a   Ramos, Silvia B V ^a   Donadi, Eduardo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B lymphocytes; HLA molecule expression; Monocytes; T lymphocytes; Type 1 diabetes mellitus

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 1;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BRAZIL; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; HLA-DQ ANTIGENS; HUMANS; INFANT; MALE; T-LYMPHOCYTES;

EID: 4043137901     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.06.002     Document Type: Article

References (24)

1. Anal O., Akkoc N., Sem A., Yesil S., Yuksel F., Buyukgebiz A. MHC class I antigen expression in patients with IDDM and their siblings. J. Pediatr. Endocrinol. Metab. 10:1997;391-394
2. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., Roep B.O., Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113:2004;451-463
3. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 358:2001;221-229
4. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., Serreze D.V. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12538-12543
5. *0602 alpha beta protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus. J. Immunol. 161:1998;6439-6445
6. Faustman D., Li X., Lin H.Y., Fu Y., Eisenbarth G., Avruch J., Guo J. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science. 254:1991;1756-1761
7. Fernandes A.P.M., Foss M.C., Donadi E.A. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients. Scand. J. Immunol. 59:2004;305-309
8. Fernandes A.P.M., Louzada-Junior P., Foss M.C., Donadi E.A. HLA-DRB1, DQB1, and DQA1 allele profile in Brazilian patients with type 1 diabetes mellitus. Ann. N. Y. Acad. Sci. 958:2002;305-308
9. Foulis A.K. The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus. A.P.M.I.S. 104:1996;161-167
10. Hao W., Gladstone P., Engardt S., Greenbaun C., Palmer J.P. Major histocompatibility complex class I molecule expression is normal on peripheral blood lymphocytes from patients with insulin-dependent diabetes mellitus. J. Clin. Invest. 98:1996;1613-1618
11. Huang J.F., Yang Y., Sepulveda H., Shi W., Hwang I., Peterson P.A., Jackson M.R., Sprent J., Cai Z. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science. 286:1999;952-954
12. Hwang I., Huang J.F., Kishimoto H., Brunmark A., Peterson P.A., Jackson M.R., Surh C.D., Cai Z., Sprent J. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 191:2000;1137-1148
13. Keskinen P., Ronni T., Matikainen S., Lehtonen A., Julkunen I. Regulation of HLA class I and II expression by interferons and influenza A vírus in human peripheral blood mononuclear cells. Immunology. 91:1997;421-429
14. Miller A.S., Dykes D.D., Olesky H.F. A simple salting-out procedure for extraction of DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1255
15. Nepom G.T., Erlich H. MHC class II molecules and autoimmunity. Ann. Rev. Immunol. 9:1991;493-525
16. Patel D.M., Arnold P.Y., White G.A., Nardella J.P., Mannie M.D. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J. Immunol. 163:1999;5201-5210
17. Rabinovitch A., Suarez-Pinzon W.L. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 55:1998;1139-1149
18. Raz I., Elias D., Avron A., Tamir M., Metzger M., Cohen I.R. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet. 358:2001;1749-1753
19. Roivainen M., Knip M., Hyoty H., Kulmala P., Hiltunen M., Vahasalo P., Hovi T., Akerblom H.K. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. J. Med. Virol. 56:1998;74-78
20. Serreze D.V., Leiter E.H., Christianson G.J., Greiner D., Roopenian D.C. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes. 43:1994;505-509
21. She J.X. Susceptibility to type 1 diabetes: HLA-DQ and DR revised. Immunol. Today. 17:1996;323-329
22. Sjostrom A., Eriksson M., Cerboni C., Johansson M.H., Sentman C.L., Karre K., Hoglund P. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors. J. Exp. Med. 194:2001;1519-1530
23. Wy N.G., Thai A.C., Lui K.F., Yeo P.P., Cheah J.S. Systemic levels of cytokines and GAD-specific autoantibody isotypes in Chinese IDDM patients. Diabetes Res. Clin. Pract. 43:1999;127-135
24. Yoon J.W., Jun H.S., Santamaria P. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity. 27:1998;109-122